icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 25 Jun 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Registered with the Digital Government Authority under number:
20250831619
Suggestions

Important Information on the Correct Use of Spiriva and Foradil Capsules

Important Information on the Correct Use of Spiriva and Foradil Capsules

icon التاريخ: 2008-03-03
نوع المواضيع: General Health

<p>

<font size="2">    On 29, February 2008 , the Food And Drug Administration (FDA) the </font>
<a name="OLE_LINK1">
<font >American's equivalent to the Saudi Food and Drug Authority (SFDA)</font>
</a>
<font size="2"> and the American Association of Poison Control Center’s (AAPCC) National Poison Data System have received many reports of patients swallowing Foradil and Spiriva capsules rather than placing the capsules in the inhalation devices. Reports of ingestions indicate that few patients experienced side effects from the swallowed capsules. </font>

</p>
<p><font size="2">    Both products Spiriva (tiotropium bromide inhalation powder) Capsules and <br />Foradil (formoterol fumarate inhalation powder) Capsules are to be used in the HandiHaler (Spiriva) and Aerolizer (Foradil) devices to deliver the medicine to the lungs to improve breathing in patients with asthma, and in individuals affected by chronic obstructive lung disease and bronchitis.</font></p>
<p><font size="2">    Both products will not treat a patient's breathing condition if the contents of a capsule are swallowed rather than inhaled.</font></p>
<p><font size="2">    Doctors, nurses, and pharmacists should discuss with patients how to correctly use the Spiriva HandiHaler or Foradil Aerolizer. If a patient who is prescribed Spiriva or Foradil does not experience breathing improvement, the health care provider should ask the patient if he or she is swallowing the medicine rather than inhaling it. </font></p>
<p><font size="2"><font ><b><br />FDA is highlighting for patients the following information on the correct use of Spiriva and Foradil capsules:</b> </font></font></p>
<ul type="disc">
<li><font size="2">Do not swallow the Spiriva or Foradil capsules.</font></li></ul>
<ul type="disc">
<li><font size="2">The contents of Spiriva and Foradil capsules are only to be inhaled using their respective inhalation devices. Remove the capsule from the blister package and place the intact capsule into the inhalation device prior to inhalation.</font></li></ul>
<ul type="disc">
<li><font size="2">Follow the instructions contained in the patient information leaflet provided with your prescription explaining how to use the Spiriva Handihaler or Foradil Aerolizer .</font></li></ul>
<p><font size="2"></font></p>
<p><b><font size="2">REPORT A<i>DVE</i>RSE DRUG REACTIONS TO THE SAUDI FDA </font></b></p>
<p><font size="2">The public and health professionals are encouraged to report adverse drug reactions the National Pharmacovigilance Center on the Internet at: </font></p>
<p></p>
<p><font size="2"></font></p>
<p align="left"><font size="2"></font> </p>

Important Information on the Correct Use of Spiriva and Foradil Capsules